Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?

To: John Arnopp who wrote (1552)	7/26/1998 10:10:00 AM
From: robert miller	Read Replies (2) \| Respond to of 4467

John, I believe the recent weakness is due, at least in part, to their announcement that ICG may come out as a traditional IPO instead of a rights offering. We all believe that through SFE we can participate in companies going public. If the perception changes and investors believe that SFE will not take the best companies public through the rights offering process, then SFE itself becomes less desirable. I believe the recent premium of around $6 was due in large part to ICG. That is completely gone now and if SFE does announce that ICG will be a traditional IPO , I believe we will be trading below the NAV of the public companies. SFE may have a problem with their partners in ICG, but they better solve it or they will have a real problem with their own shareholders. Earlier this year Pete stated he would agree with the analyst target of $60 for year end. How they handle the ICG situation will determine if they have any chance for $60. [IMO] bob